Yang Yang, Feng Yuyao, Zhang Xiaowei, Nakajima Takero, Tanaka Naoki, Sugiyama Eiko, Kamijo Yuji, Aoyama Toshifumi
Department of Metabolic Regulation, Shinshu University Graduate School of Medicine.
Tohoku J Exp Med. 2016 Oct;240(2):113-22. doi: 10.1620/tjem.240.113.
Very-long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the first reaction in the mitochondrial fatty acid β-oxidation pathway. VLCAD deficiency is associated with the accumulation of fat in multiple organs and tissues, which results in specific clinical features including cardiomyopathy, cardiomegaly, muscle weakness, and hepatic dysfunction in infants. We speculated that the abnormal fatty acid metabolism in VLCAD-deficient individuals might cause cell necrosis by fatty acid toxicity. The accumulation of fatty acids may activate peroxisome proliferator-activated receptor (PPAR), a master regulator of fatty acid metabolism and a potent nuclear receptor for free fatty acids. We examined six skin fibroblast lines, derived from VLCAD-deficient patients and identified fatty acid accumulation and PPARα activation in these cell lines. We then found that the expression levels of three enzymes involved in fatty acid degradation, including long-chain acyl-CoA synthetase (LACS), were increased in a PPARα-dependent manner. This increased expression of LACS might enhance the fatty acyl-CoA supply to fatty acid degradation and sulfatide synthesis pathways. In fact, the first and last reactions in the sulfatide synthesis pathway are regulated by PPARα. Therefore, we also measured the expression levels of enzymes involved in sulfatide metabolism and the regulation of cellular sulfatide content. The levels of these enzymes and cellular sulfatide content both increased in a PPARα-dependent manner. These results indicate that PPARα activation plays defensive and compensative roles by reducing cellular toxicity associated with fatty acids and sulfuric acid.
极长链酰基辅酶A脱氢酶(VLCAD)催化线粒体脂肪酸β-氧化途径中的第一步反应。VLCAD缺乏与多个器官和组织中的脂肪积累有关,这会导致特定的临床特征,包括婴儿的心肌病、心脏肥大、肌肉无力和肝功能障碍。我们推测,VLCAD缺乏个体中异常的脂肪酸代谢可能通过脂肪酸毒性导致细胞坏死。脂肪酸的积累可能会激活过氧化物酶体增殖物激活受体(PPAR),它是脂肪酸代谢的主要调节因子,也是游离脂肪酸的强效核受体。我们检查了来自VLCAD缺乏患者的六种皮肤成纤维细胞系,并在这些细胞系中发现了脂肪酸积累和PPARα激活。然后我们发现,参与脂肪酸降解的三种酶的表达水平,包括长链酰基辅酶A合成酶(LACS),以PPARα依赖的方式增加。LACS的这种表达增加可能会增强脂肪酸降解和硫脂合成途径的脂肪酰基辅酶A供应。事实上,硫脂合成途径中的第一步和最后一步反应受PPARα调节。因此,我们还测量了参与硫脂代谢的酶的表达水平以及细胞硫脂含量的调节。这些酶的水平和细胞硫脂含量均以PPARα依赖的方式增加。这些结果表明,PPARα激活通过降低与脂肪酸和硫酸相关的细胞毒性发挥防御和补偿作用。